ABSTRACT Introduction Female sexual dysfunctions (FSDs) are common in women of any
age and have a huge impact on quality of life and relationships. They have a multifaceted …

Hypoactive sexual desire disorder (HSDD) in women is defined as the persistent or
recurrent absence of sexual thoughts or fantasies and/or lack of desire for sexual activity that …

Marriage and the Family: Mirror of a Diverse Global Society is a comprehensive text about
marriage and the family in sociology, family science, and diversity studies. The book is …

Objective Hypoactive sexual desire disorder (HSDD) in women has been viewed
inaccurately by some in the medical and payer community as analogous to erectile …

Flibaserin is a drug for the treatment of hypoactive sexual desire disorder in pre-menopausal
women. Four solid forms of flibanserin were discovered, including form A, form I, form II, and …

Hypoactive sexual desire disorder (HSDD) is a widely known type of female sexual
dysfunction that could also cause emotional distress and relationship problems. Flibanserin …

Flibanserin (brand name Addyi) is indicated for the treatment of “hypoactive sexual desire
disorder”(HSDD) in premenopausal women. It is the first drug to be approved by the FDA for …

Background: The impact of nipple sensation and its relationship to sexual function have
often been neglected in medical literature. However, several recent studies report the …

Sexual health is one of the significant aspects of health for men and women. Sexual
disorders (SD) have been a common problem in all societies at all times and affect the …

Introduction: Introduction of the oral phosphodiesterase isoenzyme-5 inhibitors (PDE5-Is)
has revolutionized sexual medicine by affording effective treatment for erectile dysfunction …